Advances in inner ear gene therapy: Exploring cochlear protection and regeneration

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 13, Issue 5, 2005, Pages 308-312

  Maiorana, Carrie R ^a   Staecker, Hinrich ^a,b  

^a UNIVERSITY OF KANSAS   (United States)

^b MS 3010 ^*  (United States)

Author keywords

Cochlea; Cochlear protection; Cochlear regeneration; Gene therapy; Inner ear

Indexed keywords

ADENOVIRUS VECTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; GROWTH FACTOR; HERPESVIRUS VECTOR; LIPOSOME; NEUROTROPHIN 3; PARVOVIRUS VECTOR;

ACTION POTENTIAL; CELL PROTECTION; CELL TRANSFORMATION; COCHLEA; COCHLEA INJURY; COCHLEA PROSTHESIS; DEGENERATIVE DISEASE; DISEASE MODEL; GENE FUNCTION; GENE THERAPY; HAIR CELL; HEARING; ISCHEMIA; MARKER GENE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OTOTOXICITY; PHENOTYPE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SPIRAL GANGLION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; COCHLEA; EAR, INNER; GENE THERAPY; HUMANS; LABYRINTH DISEASES;

EID: 25144525150     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000179248.51476.11     Document Type: Review

References (48)

1. Lalwani AK, Mhatre AN. Cochlear gene therapy. Ear Hear 2003; 24:342-348.
2. Staecker H, Brough DE, Praetorius M, Baker K. Drug delivery to the inner ear using gene therapy. Otolaryngol Clin North Am 2004; 37:1091-1108.
3. Raphael Y, Frisancho JC, Roessler BJ. Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci Lett 1996; 207:137-141.
4. Weiss MA, Frisancho JC, Roessler BJ, Raphael Y. Viral-mediated gene transfer in the cochlea. Int J Dev Neurosci 1997; 15:577-583.
5. Dazert S, Battaglia A, Ryan AF. Transfection of neonatal rat cochlear cells in vitro with an adenovirus vector. Int J Dev Neurosci 1997; 15:595-600.
6. Kanzaki S, Ogawa K, Camper SA, Raphael Y. Transgene expression in neonatal mouse inner ear explants mediated by first and advanced generation adenovirus vectors. Hear Res 2002; 169:112-120.
7. Luebke AE, Steiger JD, Hodges BL, Amalfitano A. A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function. Gene Ther 2001; 8:789-794.
8. Praetorius M, Baker K, Weich CM, et al. Hearing preservation after inner ear gene therapy: the effect of vector and surgical approach. ORL J Otorhinolaryngol Relat Spec 2003; 65:211-214.
9. Ishimoto S, Kawamoto K, Stover T, et al. A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea. Audiol Neurootol 2003; 8:70-79.
10. Rasmussen H, Chu KW, Campochiaro P, et al. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Hum Gene Ther 2001; 12:2029-2032.
11. Lalwani AK, Walsh BJ, Reilly PG, et al. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Ther 1996; 3:588-592.
12. Lalwani AK, Walsh BJ, Carvalho GJ, et al. Expression of adeno-associated virus integrated transgene within the mammalian vestibular organs. Am J Otol 1998; 19:390-395.
13. Luebke AE, Foster PK, Muller CD, Peel AL. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum Gene Ther 2001; 12:773-781.
14. Li DM, Bordet T, Mezzina M, et al. Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea. Neuroreport 2002; 13:1295-1299.
15. Stone IM, Lurie DI, Kelley MW, Poulsen DJ. Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea. Mol Ther 2005; 11:843-848. This study clearly demonstrates that a tissue-specific promoter can be used to define gene expression in a subset of auditory cells.
16. Di Pasquale G, Rzadzinska A, Schneider ME, et al. A novel bovine virus efficiently transduces inner ear neuroepithelial cells. Mol Ther 2005; 11:849-855.
17. Staecker H, Gabaizadeh R, Federoff H, Van De Water TR. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 1998; 119:7-13.
18. Derby ML, Sena-Esteves M, Breakefield XO, Corey DP. Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res 1999; 134:1-8.
19. Staecker H, Li D, O'Malley BW Jr, Van De Water TR. Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol 2001; 121:157-163.
20. Wareing M, Mhatre AN, Pettis R, et al. Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear Res 1999; 128:61-69.
21. Kawakami S, Yamashita F, Nishida K, et al. Glycosylated cationic liposomes for cell-selective gene delivery. Crit Rev Ther Drug Carrier Syst 2002; 19:171-190.
22. Han JJ, Mhatre AN, Wareing M, et al. Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector. Hum Gene Ther 1999; 10:1867-1873.
23. Carvalho GJ, Lalwani AK. The effect of cochleostomy and intracochlear infusion on auditory brain stem response threshold in the guinea pig. Am J Otol 1999; 20:87-90.
24. Jero J, Tseng CJ, Mhatre AN, Lalwani AK. A surgical approach appropriate for targeted cochlear gene therapy in the mouse. Hear Res 2001; 151:106-114.
25. Stover T, Yagi M, Raphael Y. Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther 2000; 7:377-383.
26. Kho ST, Pettis RM, Mhatre AN, Lalwani AK. Safety of adeno-associated virus as cochlear gene transfer vector: analysis of distant spread beyond injected cochleae. Mol Ther 2000; 2:368-373.
27. Yamasoba T, Yagi M, Roessler BJ, et al. Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic Sac. Hum Gene Ther 1999; 10:769-774.
28. Stover T, Kawamoto K, Kanzaki S, Raphael Y. Feasibility of inner ear gene transfer after middle ear administration of an adenovirus vector. Laryngorhinootologie 2001; 80:431-435.
29. Ishimoto S, Kawamoto K, Kanzaki S, Raphael Y. Gene transfer into supporting cells of the organ of Corti. Hear Res 2002; 173:187-197.
30. Sugahara K, Shimogori H, Okuda T, et al. Novel method for homogeneous gene transfer to the inner ear. Acta Otolaryngol 2004; (Suppl):19-22.
31. Kawamoto K, Oh SH, Kanzaki S, et al. The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther 2001; 4:575-585.
32. Praetorius M, Knipper M, Schick B, et al. A novel vestibular approach for gene transfer into the inner ear. Audiol Neurootol 2002; 7:324-334.
33. Oshima K, Shimamura M, Mizuno S, et al. Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats. FASEB J 2004; 18:212-214. This study used a novel nonviral vector to prevent aminoglycoside ototoxicity.
34. Boeda B, Weil D, Petit C. A specific promoter of the sensory cells of the inner ear defined by transgenesis. Hum Mol Genet 2001; 10:1581-1589.
35. Chen X, Frisina RD, Bowers WJ, et al. HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage. Mol Ther 2001; 3:958-963.
36. Bowers WJ, Chen X, Guo H, et al. Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea. Mol Ther 2002; 6:12-18.
37. Nakaizumi T, Kawamoto K, Minoda R, Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 2004; 9:135-143.
38. Yagi M, Kanzaki S, Kawamoto K, et al. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 2000; 1:315-325.
39. Kanzaki S, Stover T, Kawamoto K, et al. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol 2002; 454:350-360.
40. Suzuki M, Yagi M, Brown JN, et al. Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Ther 2000; 7:1046-1054.
41. Kawamoto K, Yagi M, Stover T, et al. Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ther 2003; 7:484-492.
42. Hakuba N, Watabe K, Hyodo J, et al. Adenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbils. Gene Ther 2003; 10:426-433.
43. Kawamoto K, Sha SH, Minoda R, et al. Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther 2004; 9:173-181.
44. Bermingham NA, Hassan BA, Price SD, et al. Math1: an essential gene for the generation of inner ear hair cells. Science 1999; 284:1837-1841.
45. Zheng JL, Gao WQ. Overexpression of Math1 induces robust production of extra hair cells in postnatal rat inner ears. Nat Neurosci 2000; 3:580-586.
46. Shou J, Zheng JL, Gao WQ. Robust generation of new hair cells in the mature mammalian inner ear by adenoviral expression of Hath1. Mol Cell Neurosci 2003; 23:169-179.
47. Kawamoto K, Ishimoto S, Minoda R, et al. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 2003; 23:4395-4400.
48. Izumikawa M, Minoda R, Kawamoto K, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005; 11:271-276. This is the first paper to demonstrate functional hair cell regeneration by the use of gene therapy. Although the outer hair cells seen after math 1 gene therapy are not normal in appearance, this study promises that gene therapy may be an approach for hearing restoration.